References
- Babu CK, Khanna SK, Das M. Safety evaluation studies on agremone oil through dietary exposure for 90 days in rats. Food and Chemical Toxicology 2006; 44: 1151–1157
- Brossi A, Borer R. Analysis and purification of a commercial sample of sanguinarine nitrate. Lloydia 1965; 28: 199–202
- Das M, Khanna K. Clinicoepidemiological, toxicological, and safety evaluation studies on argemone oil. Critical Reviews in Toxicology 1997; 27: 273–297
- Dvořák Z, Šimánek V. Metabolism of sanguinarine: The facts and the myths. Current Drug Metabolism 2007; 8: 173–176
- Dvořák Z, Zdařilová A, Šperlíková L, Anzenbacherová E, Šimánek V, Ulrichová J. Cytotoxicity of sanguinarine in primary rat hepatocytes is attenuated by dioxin and phenobarbital. Toxicology Letters 2006; 165: 282–288
- Evans EA. Tritium and its compounds. Wiley and Sons, New York 1974
- Hakim SA, Mijovic V, Walker J. Experimental transmission of sanguinarine in milk: Detection of a metabolic product. Nature 1961; 189: 201–204
- Psotová J, Klejdus B, Večeřa R, Kosina P, Kubáň V, Vičar J, Šimánek V, Ulrichová J. A liquid chromatographic-mass spectrometric evidence of dihydrosanguinarine as a first metabolite of sanguinarine transformation in rat. Journal of Chromatography B, Analytical Technologies in the Biomedical and Life Sciences 2006; 830: 165–172
- Southon IW, Buckingham J. Dictionary of alkaloids. Chapman and Hall, London 1989
- Stiborová M, Šimánek V, Frei E, Hobza P, Ulrichová J. DNA adduct formation from quaternary benzo[c]phenanthridine alkaloids sanguinarine and chelerythrine as revealed by the 32P-postlabeling technique. Chemico-Biological Interactions 2002; 140: 213–242
- Tandon S, Das M, Khanna SK. Biometabolic elimination and organ retention profile of argemone alkaloid, sanguinarine, in rats and guinea pigs. Drug Metabolism and Disposition 1993; 21: 194–197
- Ulrichová J, Dvořák Z, Vičar J, Lata J, Smržová J, Šedo A, Šimánek V. Cytotoxicity of natural compounds in hepatocyte cell culture models. The case of quaternary benzo[c]phenanthridine alkaloids. Toxicology Letters 2001; 125: 125–132
- Vrba J, Kosina P, Ulrichová J, Modrianský M. Involvement of cytochrome P450 1A in sanguinarine detoxication. Toxicology Letters 2004; 151: 375–387
- Walterová D, Ulrichová J, Válka I, Vičar J, Vavrečková C, Táborská E, Harkrader RJ, Meyer DL, Černá H, Šimánek V. Benzo[c]phenanthridine alkaloids saguinarine and chelerythrine: Biological activities and dental care applications. Acta Universitatis Palackianae Olomucensis (Olomouc). Faculty of Medicine 1995; 139: 7–16
- Williams MK, Dalvi S, Dalvi RR. Influence of 3-methylcholanthrene pretreatment on sanguinarine toxicity in mice. Veterinary and Human Toxicology 2000; 42: 196–198
- Wink M. Plant secondary metabolites: Biochemistry, function and biotechnology. Biochemistry of plant secondary metabolism. Annual plant reviews, M Wink. Academic Press, Sheffield 1999; 2
- Zdařilová A, Malíková J, Dvořák Z, Ulrichová J, Šimánek V. Quaternary isoquinoline alkaloids sanguinarine a chelerythrine. Effects in vitro and in vivo. Chemicke Listy 2006; 100: 30–41